Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Todd C. Brady, M.D.,PhD$242.1M
Market Cap • 25/07/20242004
(há 20 anos)
2014
(10 years ago)
NASDAQ
Listagem
Lexington
Sede • Massachusetts15
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ALDXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.